Trial Profile
A Phase 1b, Multi-Center, Open Label, Uncontrolled, Serial Cohort, Dose Escalation Study of the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of Daily Oral Doses of ZSTK474 in Subjects With Advanced Solid Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Mar 2014
Price :
$35
*
At a glance
- Drugs OP 11 (Primary)
- Indications Anal cancer; Cholangiocarcinoma; Colorectal cancer; Gynaecological cancer; Non-small cell lung cancer; Pancreatic cancer; Soft tissue sarcoma; Solid tumours
- Focus Adverse reactions
- Sponsors Zenyaku Kogyo
- 24 Jan 2014 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 23 Oct 2013 Results presented at the 25th AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics.
- 04 Sep 2013 Planned end date changed from 1 Sep 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.